Saturday, Jun 20, 2026

Breaking

Fda S

FDA Denies Approval of Regenxbio’s Hunter Syndrome Gene Therapy

Business

FDA Denies Approval of Regenxbio’s Hunter Syndrome Gene Therapy

February 11, 2026

Novo Nordisk Sues Hims Over FDA-Controversial $49 Weight-Loss Pill

Business

Novo Nordisk Sues Hims Over FDA-Controversial $49 Weight-Loss Pill

February 10, 2026

Novo Nordisk Shares Surge as FDA Cracks Down on Illegal Drug Copies

News

Novo Nordisk Shares Surge as FDA Cracks Down on Illegal Drug Copies

February 7, 2026

ImmunityBio Stock Jumps 26% as FDA Details ANKTIVA Resubmission Plan

Business

ImmunityBio Stock Jumps 26% as FDA Details ANKTIVA Resubmission Plan

January 21, 2026

FDA’s Expedited Drug Program Sparks Legal Questions and Concerns

Business

FDA’s Expedited Drug Program Sparks Legal Questions and Concerns

January 19, 2026

FDA’s Shift on Clinical AI Intensifies Need for AI Safety Research

News

FDA’s Shift on Clinical AI Intensifies Need for AI Safety Research

January 16, 2026

Richard Pazdur Discusses FDA Chaos in Full Video Session

Business

Richard Pazdur Discusses FDA Chaos in Full Video Session

January 14, 2026

Listeria Concerns Prompt FDA’s Highest Risk Recall of Cheese in 20 States

News

Listeria Concerns Prompt FDA’s Highest Risk Recall of Cheese in 20 States

January 14, 2026

FDA Demands Swift Improvement After “Unacceptable” Pension Management Performance

News

FDA Demands Swift Improvement After “Unacceptable” Pension Management Performance

January 13, 2026

US FDA Urges Removal of Suicide Warnings from Weight-Loss Drugs

Business

US FDA Urges Removal of Suicide Warnings from Weight-Loss Drugs

January 13, 2026

FDA Issues Recall on Dietary Supplement

Business

FDA Issues Recall on Dietary Supplement

January 12, 2026

FDA Warns Passional Boutique on Breast Binder Sales for Gender-Affirming Care

Business

FDA Warns Passional Boutique on Breast Binder Sales for Gender-Affirming Care

January 5, 2026